期刊文献+

血浆sLOX-1水平与冠状动脉慢血流的相关性 被引量:3

Correlation between plasma sLOX-1 levels and coronary slow flow phenomenon
下载PDF
导出
摘要 目的探讨血浆可溶性凝集素样氧化型低密度脂蛋白受体-1(sLOX-1)水平与冠状动脉慢血流的相关性。方法该研究共纳入82名冠脉慢血流患者(慢血流组,n=82)及184名冠脉血流正常者(对照组,n=184),采用酶联免疫吸附(ELISA)法测定两组的血浆sLOX-1水平并比较,采用参照心肌梗死溶栓治疗后(thrombolysis in myocardial infarction,TIMI)血流帧数(TFC)评价冠脉血流速度。通过多元Logistic回归分析评价血浆sLOX-1水平与合并冠心病的独立相关性,采用Spearman相关分析评价血浆sLOX-1水平与平均TMI-TFC的相关性。结果慢血流组患者血清sLOX-1水平显著高于对照组[0.94(0.48-1.30)vs 0.47(0.39-0.86)ng/ml,P<0.001]。多元Logistic回归分析显示血浆s LOX-1水平是预测冠脉慢血流独立危险因子(优势比2.044,95%可信区间1.274-3.279;P=0.003)。Spearman相关分析结果显示,血浆sLOX-1水平与TIMI-TFC呈显著正相关(rs=0.315,P=0.004)。结论血浆sLOX-1水平与冠脉慢血流的发生及严重程度存在独立正相关,sLOX-1有望成为预测冠脉慢血流风险并对其进行危险分层的重要生物标记物。 Objective To explore the correlation between plasma sLOX-1 levels and coronary slow flow phenomenon( CSFP). Methods Eighty-two patients with CSFP and 184 controls with normal coronary flow were enrolled. Plasma sLOX-1 levels were determined by enzyme-linked immunosorbent assay( ELISA) and compared between the two groups. Coronary flow rate was assessed by thrombolysis in myocardial infarction( TIMI) frame count( TFC). Multivariate Logistic regression was used to analyze the independent association between plasma sLOX-1 levels and CSFP. Spearman correlation coefficient was performed to assess the correlation between plasma sLOX-1 levels and mean-TFC. Results Plasma s LOX-1 levels in CSFP group were significantly higher than those in control group[0.94( 0.48-1.30) ng/ml vs 0.47( 0.39-0.86) ng/ml,P〈0.001]. Multivariate Logistic regression analysis demonstrated that sLOX-1 was the independent predictor of CSFP( odds ratio 2.044,95% CI 1.274-3.279; P= 0.003). Spearman correlation analysis revealed that plasma sLOX-1 level was positively correlated with mean-TFC(r=0.311,P=0.004). Conclusion The plasma sLOX-1 levels is independently associated with the presence and severity of CSFP,suggesting that sLOX-1 might be a potential biomarker for CSFP prediction and risk stratification.
出处 《山西医科大学学报》 CAS 2016年第7期589-592,共4页 Journal of Shanxi Medical University
关键词 心血管疾病 冠状动脉慢血流 可溶性凝集素样氧化型低密度脂蛋白受体-1 生物学标记物 cardiovascular disease coronary slow flow phenomenon sLOX-1 biomarker
  • 相关文献

参考文献18

  • 1Tambe AA, Demany MA, Zimmerman HA, et al. Angina pectorisand slow flow velocity of dye in coronary arteries - a new angio- graphic finding[J]. Am Heart J, 1972,84( 1 ) :66 -71.
  • 2Beltrame JF, Limaye SB, Horowitz J. The coronary slow flow phe- nomenon-a new coronary mierovaseular disorder [ J ]. Cardiology, 2002,97 (4) : 197 - 202.
  • 3Beltrame JF,Turner SP,Leslie SL,et al. The angiographie and clini- cal benefits of mibefradil in the coronary slow flow phenomenon[J].J Am Coil Cardiol,2004,44 (1) :57 -62.
  • 4Hawkins BM,Stavrakis S,Rousan TA,et al. Coronary slow flow-prev- alence and clinical correlations [ J ]. Cite J, 2012,76 ( 4 ) : 936 - 942.
  • 5Demir B, Caglar IM, Tureli HO, et al. Coronary slow flow phenom- enon associated with high serum levels of soluble CD40 ligand and urotensin ]I :a multi-marker approach [ J]. Clin Lab,2014, 60 ( 11 ) : 1909 - 1920.
  • 6Beltrame JF, Cutri N, Kopetz V, et al. The role of nitric oxide in the coronary slow flow phenomenon [ J]. Coron Artery Dis,2014, 25(3) :187 - 189.
  • 7Yoshida H, Kondratenko N, Green S,et al. Identification of the lee- tin-like receptor for oxidized low-density lipoprotein in human maerophages and its potential role as a scavenger receptor [J]. Bioehem J, 1998,334 ( Ptl ) :9 - 13.
  • 8Navarra T, Del Tureo S, Berti S,et al. The leetin-like oxidized low- density lipoprotein receptor-1 and its soluble form : cardiovascular implications [J]. J Atheroscler Thromb ,2010,17 ( 4 ) :317 - 331.
  • 9Yan M, Mehta JL, Zhang W, et al. LOX-1, oxidative stress and in- flammation : a novel mechanism for diabetic cardiovascular compli- cations [ J ]. Cardiovasc Drugs Ther, 2011,25 ( 5 ) :451 - 459.
  • 10Brinkley TE, Kume N, Mitsuoka H, et al. Variation in the human lectin-like oxidized low-density lipoprotein receptor 1 (LOX-1)gene is associated with p|asma soluble LOX-~ levels [ J ]. Exp Physio1,2008,93 (9) : 1085 - 1090.

二级参考文献16

  • 1Tambe AA, Demany MA, Zimmerman HA, et al. Angina pectoris and slow flow velocity of dye in coronary arteries--a new angio- graphic finding[J]. Am Heart J,1972,84( 1 ):66 -71.
  • 2Horjeti B, Goda A. Acute ischemia manifestation in a patient with coronary slow flow phenomenon [ J ]. J Electrocardiol, 2012,45 ( 3 ) : 277 - 279.
  • 3Hawkins BM, Stavrakis S, Rousan TA, et al. Coronary slow flow-- prevalence and clinical correlations [ J ]. Circ J, 2012,76 (4) : 936 - 942.
  • 4Demir B, Caglar IM, Tureli HO, et al. Coronary slow flow phenom- enon associated with high serum levels of soluble CD40 ligand and urotensin II:a muhi-marker approach[ J ]. Clin Lab,2014,60 ( 11 ) :1909 - 1920.
  • 5Behrame JF, Cutri N, Kopetz V, et al. The role of nitric oxide in the coronary slow flow phenomenon[ J]. Coron Artery Dis,2014, 25(3) :187 - 189.
  • 6Lassalle P,Molet S,Janin A,et al. ESM-1 is a novel human endo- thelial cell-specific molecule expressed in lung and regulated by cytokines [ J ]. J Biol Chem, 1996,271 ( 34 ) : 20458 - 20464.
  • 7Aparci M, Isilak Z, Uz O, et al. Endocan and endothelial dysfunc- tion [ J ]. Angiology ,2015,66 ( 5 ) :488 - 489.
  • 8Gibson CM, Cannon CP, Daley W,et al. TIMI frame count : a quan- titative method of assessing coronary artery flow [ J ]. Circulation, 1996,93(5) :879 -888.
  • 9Yilmaz H,Demir I,Uyar Z. Clinical and coronary angiographic char- acteristics of patients with eoronm'y slow flow[ J ]. Acta Cardio1,2008, 63(5) :579 -584.
  • 10Canga A, Cetin M, Kocaman SA, et al. Increased serum resistin levels in patients with coronary slow-flow phenomenon [ J ]. Herz, 2013,38 (7) :773 - 778.

共引文献4

同被引文献26

引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部